Is it safe to administer remdesivir and daptomycin simultaneously through a Y-site in an intravenous line?
Abstract
Simultaneous administration of remdesivir and daptomycin through a Y-site in an intravenous line is not considered safe due to lack of compatibility data and is generally advised against by drug manufacturers.
Fields of Study & Subjects
Intravenous Infusion Technology and Safety
Antibiotics Pharmacokinetics and Efficacy
Central Venous Catheters and Hemodialysis
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 12 January 2026
- Language
- EN